FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Krsnaa Diagnostics IPO and Windlas Biotech IPO.
Krsnaa Diagnostics IPO is a Mainline Book Built Issue IPO proposed to list at BSE, NSE while Windlas Biotech IPO is a Mainline Book Built Issue proposed to list at BSE, NSE.
Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
---|---|---|
Logo | ||
Issue Category | Mainline | Mainline |
Issue Type | IPO | IPO |
Process Type | Book Built Issue | Book Built Issue |
Listing At | BSE, NSE | BSE, NSE |
Lead Managers | Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Equirus Capital Private Limited Iifl Securities Ltd Jm Financial Limited |
Dam Capital Advisors Ltd (Formerly Idfc Securities Ltd) Iifl Securities Ltd SBI Capital Markets Limited |
Registrar | Kfin Technologies Limited | Link Intime India Private Ltd |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Krsnaa Diagnostics IPO is up to ₹1,213.33 Cr whereas the issue size of the Windlas Biotech IPO is up to ₹401.54 Cr. The final issue price of Krsnaa Diagnostics IPO is ₹954.00 per share and of Windlas Biotech IPO is ₹460.00 per share.
Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
---|---|---|
Face Value | ₹5 per share | ₹5 per share |
Issue Price (Lower) | ₹933.00 per share | ₹448.00 per share |
Issue Price (Upper) | ₹954.00 per share | ₹460.00 per share |
Issue Price (Final) | ₹954.00 per share | ₹460.00 per share |
Discount (Retail) | ||
Discount (Employee) | ₹93.00 per share | |
Market Lot Size | 15 shares | 30 shares |
Fresh Issue Size | ||
Fresh Issue Size (Amount) | up to ₹400.00 Cr | up to ₹165.00 Cr |
OFS Issue Size | 85,25,520 shares | 51,42,067 shares |
OFS Issue Size (Amount) | up to ₹813.33 Cr | up to ₹236.54 Cr |
Issue Size Total | ||
Issue Size Total (Amount) | up to ₹1,213.33 Cr | up to ₹401.54 Cr |
Krsnaa Diagnostics IPO opens on Aug 04, 2021, while Windlas Biotech IPO opens on Aug 04, 2021. The closing date of Krsnaa Diagnostics IPO and Windlas Biotech IPO is Aug 06, 2021, and Aug 06, 2021, respectively.
Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Aug 04, 2021 | Aug 04, 2021 |
Issue Close | Aug 06, 2021 | Aug 06, 2021 |
Basis Of Allotment (Tentative) | Aug 11, 2021 | Aug 11, 2021 |
Initiation of Refunds (Tentative) | Aug 12, 2021 | Aug 12, 2021 |
Credit of Share (Tentative) | Aug 13, 2021 | Aug 13, 2021 |
Listing date (Tentative) | Aug 16, 2021 | Aug 16, 2021 |
Anchor Lockin End date 1 | Sep 10, 2021 | Sep 10, 2021 |
Anchor Lockin End date 2 | Nov 09, 2021 | Nov 09, 2021 |
Krsnaa Diagnostics IPO P/E ratio is , as compared to Windlas Biotech IPO P/E ratio of .
Krsnaa Diagnostics IPO | Windlas Biotech IPO | |||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 31.62% | 78% | ||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 27.38% | 65.16% | ||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Krsnaa Diagnostics IPO retail investors (RII) are offered 12,50,874 shares while in Windlas Biotech IPO retail investors are offered 12,50,874 shares. Qualified institutional buyers (QIB) are offered 37,52,625 shares in Krsnaa Diagnostics IPO and 17,23,700 shares in Windlas Biotech IPO.
Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | ||
QIB | 37,52,625 shares | 17,23,700 shares |
NII | 18,76,312 shares | 13,23,766 shares |
RII | 12,50,874 shares | 30,88,786 shares |
Employee | 2,32,288 shares | 0 shares |
Others | ||
Total | 71,12,099 shares | 61,36,252 shares |
Krsnaa Diagnostics IPO subscribed 64.38x in total, whereas Windlas Biotech IPO subscribed 22.44x.
Krsnaa Diagnostics IPO | Windlas Biotech IPO | |
---|---|---|
QIB (times) | 49.83x | 24.40x |
NII (times) | 116.30x | 15.73x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 41.95x | 24.22x |
Employee (times) | 0.98x | |
Other (times) | ||
Total (times) | 64.38x | 22.44x |
Add a public comment...
Rs 0 Account Opening Fee
Free Eq Delivery & MF
Flat ₹20 Per Trade in F&O
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|